Publications by authors named "Concetta Crivera"

Claim this Profile
L
Literature review of occurrence, effectiveness, safety, and hospitalization burden of blood transfusion in the management of warm autoimmune hemolytic anemia.
Melca Barros, Ann Leon, Concetta Crivera, Elissa Cusson, Petya Kodjamanova

Hematology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term oral glucocorticoid use is associated with complications, healthcare resource utilization, and costs among patients with dermatomyositis or polymyositis.
Rohit Aggarwal, Qian Cai, Daniel Labson, Concetta Crivera, Federico Zazzetti

Clin Rheumatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall Survival and Treatment Patterns Among Patients With Warm Autoimmune Hemolytic Anemia in Sweden: A Nationwide Population-based Study.
Honar Cherif, Qian Cai, Concetta Crivera, Ann Leon, Iffat Rahman

Eur J Haematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximab.
Irina Murakhovskaya, Concetta Crivera, Ann Leon, Evo Alemao, Vamshi Ruthwik Anupindi

Ann Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma.
Sundar Jagannath, Nedra Joseph, Concetta Crivera, Akshay Kharat, Carolyn C Jackson

Oncol Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United States.
Sundar Jagannath, Nedra Joseph, Jinghua He, Concetta Crivera, Alex Z Fu

Oncol Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myeloma.
Daanish Hoda, Robert Richards, Edward A Faber, Abhinav Deol, Bradley D Hunter, Concetta Crivera

Future Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE-1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma.
Thomas Martin, Amrita Krishnan, Kwee Yong, Katja Weisel, Maneesha Mehra, Concetta Crivera

EJHaem· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Costs Incurred by Patients with Multiple Myeloma Following Triple Class Exposure (TCE) in the US.
Sundar Jagannath, Nedra Joseph, Jinghua He, Concetta Crivera, Alex Z Fu

Oncol Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applying State-of-the-Art Survival Extrapolation Techniques to the Evaluation of CAR-T Therapies: Evidence from a Systematic Literature Review.
Matthew Sussman, Concetta Crivera, Jennifer Benner, Nicholas Adair

Adv Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness Research for CAR-T Therapies in Multiple Myeloma: Appropriate Comparisons Require Careful Considerations of Data Sources and Patient Populations.
Nina Shah, Matthew Sussman, Concetta Crivera, Satish Valluri, Jennifer Benner

Clin Drug Investig· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes associated with endovascular treatment among patients with acute ischemic stroke in the USA.
Ansaar T Rai, Concetta Crivera, Emilie Kottenmeier, Iftekhar Kalsekar, Rashmi Kumari

J Neurointerv Surg· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization and costs associated with venous thromboembolism recurrence in patients with cancer.
Alok A Khorana, Keith R McCrae, Dejan Milentijevic, François Laliberté, Dominique Lejeune, Concetta Crivera

J Med Econ· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of machine learning methodology for the prediction of healthcare resource utilization and healthcare costs in patients with critical limb ischemia-is preventive and personalized approach on the horizon?
Jeffrey S Berger, Lloyd Haskell, Windsor Ting, Fedor Lurie, Shun-Chiao Chang, Concetta Crivera

EPMA J· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of anticoagulant therapy and VTE recurrence in patients with cancer.
Alok A Khorana, Keith R McCrae, Dejan Milentijevic, Jonathan Fortier, Winnie W Nelson, Concetta Crivera

Support Care Cancer· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care.
W Frank Peacock, Craig I Coleman, Phil Wells, Gregory J Fermann, Li Wang, Concetta Crivera

J Health Econ Outcomes Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The value of sPESI for risk stratification in patients with pulmonary embolism.
Phil Wells, W Frank Peacock, Gregory J Fermann, Craig I Coleman, Li Wang, Concetta Crivera

J Thromb Thrombolysis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endovascular Stroke Therapy Trends From 2011 to 2017 Show Significant Improvement in Clinical and Economic Outcomes.
Ansaar T Rai, Concetta Crivera, Iftekhar Kalsekar, Rashmi Kumari, Nataly Patino

Stroke· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the impact of real-world adherence to once-daily (QD) versus twice-daily (BID) non-vitamin K antagonist oral anticoagulants on stroke and major bleeding events among non-valvular atrial fibrillation patients.
Colleen A McHorney, Eric D Peterson, Veronica Ashton, François Laliberté, Concetta Crivera

Curr Med Res Opin· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Hospital Length of Stay among Patients with Low-risk Pulmonary Embolism.
Li Wang, Onur Baser, Phil Wells, W Frank Peacock, Craig I Coleman, Concetta Crivera

J Health Econ Outcomes Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation.
Alok A Khorana, Keith McCrae, Dejan Milentijevic, Nora McCormick, François Laliberté, Concetta Crivera

Am J Hematol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of real-world outcomes in patients with nonvalvular atrial fibrillation treated with direct oral anticoagulant agents or warfarin.
Manasi Datar, Concetta Crivera, Heather Rozjabek, Ibrahim M Abbass, Yihua Xu

Am J Health Syst Pharm· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-care Cost Impact of Continued Anticoagulation With Rivaroxaban vs Aspirin for Prevention of Recurrent Symptomatic VTE in the EINSTEIN-CHOICE Trial Population.
Philip S Wells, Martin H Prins, Jan Beyer-Westendorf, Anthonie W A Lensing, Lloyd Haskell, Concetta Crivera

Chest· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An answer to "anticoagulant treatment of cancer-associated venous thromboembolism: Interpreting real-world data with caution".
Michael B Streiff, Dejan Milentijevic, Keith McCrae, Daniel Yannicelli, Dominique Lejeune, Concetta Crivera

Am J Hematol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism.
Jeffrey S Berger, Roger Seheult, François Laliberté, Concetta Crivera, Dominique Lejeune

Res Pract Thromb Haemost· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis